News briefs: Biologic therapy doesn’t raise cancer risk in people with rheumatoid arthritis

Despite theoretical reasons to worry that biologic response modifiers may raise cancer risk, it appears they don’t significantly raise the risk of malignancy. The drugs can dramatically improve inflammation in people with rheumatoid arthritis.